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SPG13, an autosomal dominant form of pure hereditary spastic paraplegia, was recently mapped to chromosome
2q24-34 in a French family. Here we present genetic data indicating that SPG13 is associated with a mutation, in
the gene encoding the human mitochondrial chaperonin Hsp60, that results in the V72I substitution. A comple-
mentation assay showed that wild-type HSP60 (also known as “HSPD1”), but not HSP60 (V72I), together with
the co-chaperonin HSP10 (also known as “HSPE1”), can support growth of Escherichia coli cells in which the
homologous chromosomal groESgroEL chaperonin genes have been deleted. Taken together, our data strongly
indicate that the V72I variation is the first disease-causing mutation that has been identified in HSP60.
Hereditary spastic paraplegia (HSP) represents a
clinically and genetically heterogeneous group of
neurodegenerative disorders that are characterized by
progressive spasticity and weakness of the lower
limbs. Seventeen different loci have been mapped, but
only five of the corresponding genes have been cloned
and identified so far (for reviews, see Tallaksen et al.
2001 and Casari and Rugarli 2001; for the recently
identified fifth gene, see Zhao et al. 2001). Two of
these five gene products—paraplegin (SPG7 [MIM
*602783]) (Casari et al. 1998) and spastin (SPG4
[MIM 182601]) (Hazan et al. 1999)—feature AAA
domains and are predicted to possess chaperone ac-
tivity. Paraplegin is the human homologue of a yeast
protease/chaperone that is involved in mitochondrial
protein quality control (Casari et al. 1998; Langer
2000). We had previously localized the genes encoding
the human mitochondrial chaperonin Hsp60 (heat-
shock protein 60; also known as “Cpn60”) and its
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co-chaperonin Hsp10 (heat-shock protein 10; also
known as “Cpn10”) to chromosome 2q33.1—that is,
to the same region to which another locus for HSP
(SPG13 [MIM *605280]) had been mapped in a
French family (Fontaine et al. 2000)—which
prompted us to propose that HSP60 and HSP10 are
candidate genes for SPG13. After determination of the
HSP60/HSP10 genomic structure (HSPD1 [GenBank
accession number AJ250915]), sequencing of the 16
exons encoding the two genes and the intervening
656-bp bidirectional promoter region in two affected
members of the family with SPG13 revealed that both
individuals were heterozygous for a GrA variation at
position 292 of the HSP60 cDNA, resulting in the
substitution of a valine residue at position 72 in ma-
ture Hsp60 with isoleucine (V72I). Sequencing of
HSP60 exon 3 in the other members of the SAL-612
family confirmed that the variant allele segregated
with the disease (fig. 1), and a peak two-point LOD
score of 3.43 at recombination fraction 0, similar to
that calculated for D2S2392, was obtained for this
variant allele (Fontaine et al. 2000). Since the pene-
trance of HSP is age dependent, a possible explanation
for the observation that three individuals (II:10, IV:
1, and IV:2) are not clinically affected even though
they carry both the disease allele and the mutation is
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Figure 1 Pedigree of family SAL-612. SPG13 is flanked by D2S2195 and D2S309. The haplotype segregating with HSP is indicated, and
recombinants are noted by an arrow. The plus sign identifies the individuals in whom the HSP60 292 GrA variant was found. A perfect
segregation is observed between the disease haplotype and the HSP60 292 GrA variant.
that they were younger than the mean age at onset of
SPG13 at the time of clinical examination. Analysis
of genomic DNA from unrelated control individuals
of European descent showed that none of 800 control
chromosomes carried the 292GrA variation.
To further investigate the frequency of HSP60 vari-
ations in a population of patients with HSP, we se-
quenced the coding region and the promoter of the
HSP10 and HSP60 genes in four affected individuals
belonging to two French families in which linkage to
chromosome 2q24-34 was suggested (Fontaine et al.
2000) and in 20 index cases with autosomal dominant
HSP from French families, which were not informative
enough to be investigated by linkage analysis, and in
which mutations in the gene encoding spastin (i.e.,
SPG4) had been excluded. In only one of these patients,
we found a base pair change that resulted in an amino
acid substitution—an ArG variation at position 551 of
the HSP60 cDNA, replacing asparagine-158 with serine
(N158S). However, the absence of this variation in an-
other affected family member, as well as its presence in
1 of 800 alleles from control individuals of European
descent, suggested that it represents a rare variation and
not a disease-causing mutation.
In an alignment of human Hsp60 with the Escherichia
coli Hsp60 homologue GroEL, valine-72 and aspara-
gine-158 correspond to valine-74 and lysine-160 in E.
coli GroEL, respectively. Inspection of the crystal struc-
ture of E. coli GroEL (Xu et al. 1997) shows that valine-
74 is located in helix C of the equatorial domain, buried
inside a conserved substructure of the GroEL monomer,
whereas lysine-160 is situated in the intermediate do-
main and its side chain protrudes from the outer surface
of the barrel structure (fig. 2). This suggests that re-
placement of the conserved valine may have more-severe
consequences than replacement at the other position. To
experimentally determine the function of the HSP60
(V72I) and HSP60 (N158S) variants, we turned our at-
tention to the E. coli genetic system. The groESgroEL
operon encoding the E. coli chaperonins is essential for
bacterial growth under a variety of growth conditions
(Fayet et al. 1989). We have recently shown that the
entire E. coli groESgroEL chromosomal operon can be
deleted when the human HSP60 and HSP10 genes are
supplied in trans (Richardson et al. 2001). However, the
resulting E. coli–derivative strain grows slowly, at 37C,
or not at all, at 42C. Thus, we reasoned that the ability
of the HSP60 and HSP10 human chaperone genes to
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Figure 2 Schematic representation of the structure of the Hsp60 chaperonin homologue GroEL from E. coli (Protein Data Bank entry
1AON). The architecture of a subunit in the closed and open conformations and an overview of the GroEL/GroES chaperonin complex with
one subunit in the closed (upper ring) and open (lower ring) conformations highlighted in black are shown. The side chains of valine-74 and
lysine-160, which correspond to valine-72 and asparagine-158, respectively, in human Hsp60, are shown in space-filling representation. The
figure was produced with WebLab ViewerLite software (Molecular Simulations).
replace the endogenous groESgroEL operon may rep-
resent a very sensitive system to test our two HSP60
mutant alleles for their relative in vivo function.
We found that when either the E. coli wild-type
(wt) groESgroEL operon or the human HSP60
(wt)–HSP10 (wt) or Hsp60 (N158S)–HSP10 (wt)
set of genes was expressed from a plasmid, they al-
lowed the deletion of the chromosomally encoded
groESgroEL operon—that is, ∼50% of the tetracy-
cline-resistance (TetR) transductants simultaneously
inherited the q-chloramphenicol-resistance (CamR)–
encoding cassette, replacing the groESgroEL operon
(for details, see the note for table 1). In contrast, the
presence of the HSP60 (V72I)–HSP10 (wt) set of
genes on a plasmid did not allow the deletion of the
groESgroEL chromosomally encoded operon—that
is, none of the TetR transductants (0/206) inherited
the CamR-encoding DNA cassette. The E. coli trans-
ductants maintained alive by either the HSP60
(wt)–HSP10 (wt) or HSP60 (N158S)–HSP10 (wt) op-
eron could not be distinguished from each other by a
variety of physiological and genetic tests. For exam-
ple, the colony sizes of the two E. coli strains were
indistinguishable from each other, and both strains
failed to grow at 40C. In addition, both strains
supported equally well the growth of bacteriophage
T5, which requires both the GroES and GroEL pro-
teins for its morphogenesis (Richardson et al. 2001).
In contrast, neither strain supported the growth, at
37C, of bacteriophage l, T4, RB43, and RB49, in
agreement with our previous results (Richardson et
al. 2001). The following control experiments were
performed to ensure the validity of our results and
conclusions (fig. 3): first, western blot analysis indi-
cated that all plasmid constructs expressed equal lev-
els of Hsp60; second, western blot analysis with
GroEL-specific antibody showed that CamR E. coli
transductants did not express any GroEL, as expected;
and, third, the three HSP60 plasmid constructs intro-
duced into the E. coli B178 bacteria (table 1) were
shown by DNA sequencing to possess the correct
HSP60 allele (data not shown).
The inevitable conclusion of all our genetic and pro-
tein-expression experiments is that, whereas the Hsp60
(N158S) mutant protein functions as well as its Hsp60
wt counterpart in the promotion of E. coli growth, the
Hsp60 (V72I) mutant protein fails to do so. Dominant
inheritance of the HSP60 (V72I) allele in spastic para-
plegia may result from haploinsufficiency through the
formation of mixed chaperonin rings consisting of active
wt and functionally incapacitated Hsp60 (V72I) sub-
units. This would lead to a lowering of overall chape-
ronin activity, especially under stress conditions inwhich
the up-regulation of the wt allele cannot fully compen-
sate for the nonfunctional allele. Alternatively, Hsp60
(V72I) chaperonin subunits may perturb allosteric cou-
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Figure 3 Western blot analysis of Hsp60 and GroEL protein ex-
pression. E. coli B178 cells transformed with the plasmids carrying the
cDNA for human HSP10 and wt or variant HSP60 (see table 1) or cells
transformed with the vector plasmid were grown in dYT medium to
midlog phase. Expression of plasmid-encoded chaperonins was induced
for 3 h by addition of 1 mM IPTG. One of the groESgroEL deleted
colonies that was maintained alive with plasmid pOFX HSP60 (wt)–
HSP10 (wt) was grown overnight in dYT medium that was supple-
mented with 1 mM IPTG. Soluble extracts prepared as described else-
where (Bross et al. 1995) were subjected to SDS-PAGE and western blot
analysis through use of monoclonal antibodies that were directed against
Hsp60 (H-3524; Sigma) and GroEL (SPA 870; StressGen), respectively.
Blots were developed using ECL (Amersham Biosciences) and were
scanned using a STORM molecular imager. The strain genotypes with
respect to chromosomal groESgroEL and plasmid-expressed human
Hsp60 variant and the amount of total protein loaded per lane are
indicated at the top. The position and molecular mass (in kD) of co-
electrophoresed marker proteins are indicated at the right margin.
Table 1
Replacement of the E. coli Chromosomally Encoded groESgroEL





None 105 0 0
pOFX groESgroEL 114 59 49
pOFX HSP60 (wt)–HSP10 (wt) 218 100 46
pOFX HSP60 (N158S)–HSP10 (wt) 216 108 50
pOFX HSP60 (V72I)–HSP10 (wt) 206 0 0
NOTE.—A bacteriophage P1 lysate was first prepared on the donor
strain AR189, a derivative of OF3465 (a kind gift from Drs. Marie-
Pierre Castanie´ and Olivier Fayet, Centre National de Recherche Scien-
tifiq, Toulouse), in which the groESgroEL operon has been deleted and
replaced by a CamR DNA cassette (Richardson et al. 2001). The
groESgroEL-deleted strain is maintained alive with plasmid pOFX
groESgroEL (Castanie et al. 1997). In addition, AR189 carries a Tn10
insertion, zid1::Tn10, that encodes TetR and is∼50%cotransferablewith
the groESgroEL operon by bacteriophage P1 transduction (Fayet et al.
1989). The resulting P1 lysate was used to infect the bacterial strain
B178 transformed with derivatives of plasmid pOFX-tac1 (Castanie et
al. 1997) carrying the cDNA for humanHSP10 andwt or variantHSP60
(without mitochondrial transit peptide) as an operon under control of
the tac promoter. Nontransformed cells or cells that were transformed
with a plasmid that carried the E. coli groESgroEL operon were used
as controls. After removal of unadsorbed P1 bacteriophage by centrif-
ugation, cells were spread on plates that were supplemented with 103M
isopropyl-b-D-thiogalactopyranoside (IPTG), 12.5 mg/ml of tetracycline
and M sodium citrate (to prevent bacteriophage P1 re-ad-35# 10
sorption). After a 48-h incubation at 30C, TetR colonies were replica
plated onto LB-agar plates supplementedwith 10mg/ml chloramphenicol
and IPTG, tetracycline, and sodium citrate, as described above, andwere
scored after a 48-h incubation at 30C, for acquisition of the CamR
marker. Inheritance of the CamR phenotype indicates that the endoge-
nous, chromosomally encoded groESgroEL operon has been successfully
deleted and replaced by the CamR-encoding DNA cassette.
a The values represent the number of transductants and are the result
of a single experiment, for recipient bacteria carrying no plasmid or
pOFX groESgroEL, and the sum of two independent experiments, for
the rest of the constructs.
pling between the subunits in the ring structure and thus
exert a genuine dominant negative effect.
Taken together, our studies strongly suggest that the
V72I amino acid change that is caused by the 292GrA
mutation in HSP60 is responsible for SPG13. That three
(SPG4, SPG7, and SPG13) of the six genes for HSP that
have been identified so far encode proteins with putative
chaperone activity supports the hypothesis that a sig-
nificant fraction of the HSPs are “chaperonopathies.”
The detection of the first disease-causing mutation in the
biochemically well-characterized Hsp60 chaperonin en-
ables the investigation of the mechanisms by which mu-
tations in the various chaperone genes predominantly
manifest in the distal regions of the very long axons of
the corticospinal tract. A role of chaperones is increas-
ingly recognized in neurodegenerative diseases (Slavo-
tinek and Biesecker 2001), and our findings lend further
weight to the notion that chaperones play an important
role in neurodegenerative diseases in general.
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